Tsutsui Yuko, Kuri Barbara, Sengupta Tanusree, Wintrode Patrick L
Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106, USA.
J Biol Chem. 2008 Nov 7;283(45):30804-11. doi: 10.1074/jbc.M804048200. Epub 2008 Sep 15.
The serpinopathies are a group of inherited disorders that share as their molecular basis the misfolding and polymerization of serpins, an important class of protease inhibitors. Depending on the identity of the serpin, conditions arising from polymerization include emphysema, thrombosis, and dementia. The structure of serpin polymers is thus of considerable medical interest. Wild-type alpha(1)-antitrypsin will form polymers upon incubation at moderate temperatures and has been widely used as a model system for studying serpin polymerization. Using hydrogen/deuterium exchange and mass spectrometry, we have obtained molecular level structural information on the alpha(1)-antitrypsin polymer. We found that the flexible reactive center loop becomes strongly protected upon polymerization. We also found significant increases in protection in the center of beta-sheet A and in helix F. These results support a model in which linkage between serpins is achieved through insertion of the reactive center loop of one serpin into beta-sheet A of another. We have also examined the heat-induced conformational changes preceding polymerization. We found that polymerization is preceded by significant destabilization of beta-sheet C. On the basis of our results, we propose a mechanism for polymerization in which beta-strand 1C is displaced from the rest of beta-sheet C through a binary serpin/serpin interaction. Displacement of strand 1C triggers further conformational changes, including the opening of beta-sheet A, and allows for subsequent polymerization.
丝氨酸蛋白酶抑制剂病是一组遗传性疾病,其分子基础是丝氨酸蛋白酶抑制剂(一类重要的蛋白酶抑制剂)的错误折叠和聚合。根据丝氨酸蛋白酶抑制剂的特性,聚合引发的病症包括肺气肿、血栓形成和痴呆。因此,丝氨酸蛋白酶抑制剂聚合物的结构具有相当大的医学研究价值。野生型α1-抗胰蛋白酶在适度温度下孵育时会形成聚合物,并且已被广泛用作研究丝氨酸蛋白酶抑制剂聚合的模型系统。通过氢/氘交换和质谱分析,我们获得了关于α1-抗胰蛋白酶聚合物的分子水平结构信息。我们发现,柔性反应中心环在聚合时受到强烈保护。我们还发现β-折叠A中心和螺旋F中的保护作用显著增强。这些结果支持了一种模型,即丝氨酸蛋白酶抑制剂之间的连接是通过一个丝氨酸蛋白酶抑制剂的反应中心环插入另一个的β-折叠A中来实现的。我们还研究了聚合前的热诱导构象变化。我们发现,聚合之前β-折叠C会发生显著的不稳定。基于我们的研究结果,我们提出了一种聚合机制,即通过二元丝氨酸蛋白酶抑制剂/丝氨酸蛋白酶抑制剂相互作用,β链1C从β-折叠C的其余部分位移出来。链1C的位移引发了进一步的构象变化,包括β-折叠A的打开,并允许随后的聚合反应。